Company Filing History:
Years Active: 1994-2017
Title: Bruce A Littlefield: Innovator in Cancer Treatment
Introduction
Bruce A Littlefield is a notable inventor based in Andover, MA (US), recognized for his contributions to cancer treatment. He holds a total of 8 patents, showcasing his innovative approach to medical science.
Latest Patents
Among his latest patents are "Methods and compositions for predicting response to eribulin," which provides methods for predicting the efficacy of eribulin in treating breast cancer by determining the level of specific biomarkers in a sample derived from the subject. Another significant patent is "Methods and compositions for use in treating cancer," which offers methods and compositions for treating diseases associated with excessive cellular proliferation, such as cancer.
Career Highlights
Bruce has worked with prominent companies in the pharmaceutical industry, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work has significantly impacted the development of treatments for cancer, demonstrating his commitment to advancing medical research.
Collaborations
Throughout his career, Bruce has collaborated with esteemed colleagues, including Murray J Towle and Boris M Seletsky, further enhancing the quality and reach of his innovative work.
Conclusion
Bruce A Littlefield's contributions to cancer treatment through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to influence the development of effective therapies for patients suffering from cancer.